Viewing nowLipiroo 40 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

MFDS item code 200709389 · Notified 2007.08.09 · Insurance code 643300670
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication is used for patients with various risk factors related to cardiovascular diseases. For example, it reduces the risk of myocardial infarction or stroke and lowers the risks associated with angioplasty and angina. It is also beneficial for patients with type 2 diabetes who have risk factors for coronary heart disease and reduces the risk of hospitalization due to congestive heart failure. At the same time, in patients with hyperlipidemia, it helps to decrease total cholesterol and LDL cholesterol levels while increasing HDL cholesterol. It is particularly effective as an adjunctive treatment when dietary control is insufficient. Overall, it is used to improve the risk of cardiovascular diseases and hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only for patients requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol measurement is recommended when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering therapies (e.g., LDL apheresis) or when such lipid-lowering therapies are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
This medication may cause abnormal muscle symptoms; therefore, it should be discontinued immediately if severe muscle pain or weakness occurs or if creatine kinase levels rise significantly. In particular, caution is required if serious myopathy or rhabdomyolysis is suspected, as it may lead to kidney function deterioration. This medication should not be used by patients with poor liver function or active liver disease, individuals with muscle disorders, pregnant women or women who may become pregnant, children under 10 years old, or those taking certain medications. Alcoholics or individuals with a history of liver disease, those with reduced kidney function, patients with hypothyroidism, and the elderly should be monitored more carefully when taking this medication. Although this medication generally has few side effects, it can exhibit various symptoms such as dyspepsia, headache, myalgia, liver function abnormalities, and allergic reactions; if any unusual symptoms occur, they should be reported. In particular, it is essential to consult a doctor immediately if muscle pain is severe or persists. This medication may interact with other drugs, so it is crucial to inform the doctor or pharmacist if any other medications are being taken. Women who are pregnant or breastfeeding should not take this medication, and fertile women should ensure appropriate contraception while on this medication. Caution is necessary for children and the elderly, as safety and efficacy have not been adequately established in these populations. There is no specific antidote for overdose, so management should be symptomatic, and liver function and muscle condition should be periodically assessed. This medication should be stored out of reach of children and kept in its original container to ensure safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture and should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and safety.
White oval film-coated tablet
30 tablets (10 tablets/PTP packaging x3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.